| Tysabri (natalizumab) |
Tysabri (natalizumab) |
| Tzield (teplizumab - mzwv) - PA, NF |
Tzield (teplizumab - mzwv) |
| Ultomiris (ravulizumab-cwvz) |
Ultomiris (ravulizumab-cwvz) |
| Unituxin (dinutuximab) |
Unituxin (dinutuximab) |
| Uplizna (inebilizumab-cdon) |
Uplizna (inebilizumab-cdon) |
| Upneeq (oxymetazoline hydrochloride) |
Upneeq (oxymetazoline hydrochloride ophthalmic solution) |
| Urea Cycle Disorder Agents - PA, NF |
Buphenyl (sodium phenylbutyrate), Olpruva (sodium phenylbutyrate), Pheburane (sodium phenylbutyrate), Ravicti (glycerol phenylbutyrate) |
| Ustekinumab – PA, NF – Standard Default |
Stelara IV (ustekinumab), Imuldosa IV (ustekinumab-srlf), Otulfi IV (ustekinumab-aauz), Pyzchiva IV (ustekinumab-ttwe), Selarsdi IV (ustekinumab-aekn), Steqeyma IV (ustekinumab-stba), Wezlana IV (ustekinumab-auub), Yesintek IV (ustekinumab-kfce), Stelara SC (ustekinumab), Imuldosa SC (ustekinumab-srlf), Otulfi SC (ustekinumab-aauz), Pyzchiva SC (ustekinumab-ttwe), Selarsdi SC (ustekinumab-aekn), Steqeyma SC (ustekinumab-stba), Wezlana SC (ustekinumab-auub), Yesintek SC (ustekinumab-kfce) |
| Vafseo (vadadustat) - PA, NF |
Vafseo (vadadustat) |
| Valchlor (mechlorethamine gel) |
Valchlor (mechlorethamine gel) |
| Vanflyta (quizartinib) |
Vanflyta (quizartinib) |
| Vanrafia (atrasentan) |
Vanrafia (atrasentan) |
| Velsipity (etrasimod) |
Velsipity (etrasimod) |
| Vemlidy (tenofovir alafenamide) - ST, NF |
Vemlidy (tenofovir alafenamide tablet) |
| Venclexta (venetoclax) |
Venclexta (venetoclax) |
| Venxxiva (tiopronin delayed-release) |
Venxxiva (tiopronin delayed-release) |
| Veopoz (pozelimab-bbfg) |
Veopoz (pozelimab-bbfg) |
| Veozah (fezolinetant) |
Veozah (fezolinetant) |
| Verkazia (cyclosporine ophthalmic emulsion 0.1%) - PA, NF |
Verkazia (cyclosporine ophthalmic emulsion 0.1%) |
| Verquvo (vericiguat) |
Verquvo (vericiguat) |